Learn about molecular testing for M. pneumoniae
Sept. 14, 2016—Donna Mayne, the microbiology, serology, and molecular laboratory manager at Sacred Heart Health System in Pensacola, Fla., outlines the clinical benefits of using molecular technology to detect Mycoplasma pneumoniae in a free program provided by Meridian Bioscience. Watch. In a separate presentation, Vicki Chalker, PhD, head of the respiratory and vaccine-preventable bacteria reference unit of Public Health England’s National Infection Service, discusses the importance of testing for M. pneumoniae and the diagnostic methodologies available. Meridian’s M. pneumoniae test recently landed FDA clearance. Watch.